1- Jalalifar S, Morovati Khamsi H, Hosseini-Fard SR, Karampoor S, Bajelan B, Irajian G, Mirzaei R. Emerging role of microbiota derived outer membrane vesicles to preventive, therapeutic and diagnostic proposes. Infectious Agents and Cancer. 2023 Dec;18(1):1-21.
2- Motamedi H, Ari MM, Shahlaei M, Moradi S, Farhadikia P, Alvandi A, Abiri R. Designing multi-epitope vaccine against important colorectal cancer (CRC) associated pathogens based on immunoinformatics approach. BMC bioinformatics. 2023 Feb 24;24(1):65.
3-Abkenar BR, Mohammadi A, Amoli HA, Soleimani AA, Korani M, Mahmoodi H, Najafi M. Non‐coding RNAs are correlated to TGF‐β receptor type 2 in patients with colorectal cancer. The Journal of Gene Medicine. 2023 Mar;25(3):e3472.
4- Mirshekar M, Afkhami H, Razavi S, Jazi FM, Darban-Sarokhalil D, Ohadi E, Nezhad MM, Karimi R. Potential antibacterial activity and healing effect of topical administration of bone marrow and adipose mesenchymal stem cells encapsulated in collagen-fibrin hydrogel scaffold on full-thickness burn wound infection caused by Pseudomonas aeruginosa. Burns. 2023 Jan 16.
5-Taki E, Ghanavati R, Navidifar T, Dashtbin S, Heidary M, Moghadamnia M. Ebanga™: The most recent FDA-approved drug for treating Ebola. Frontiers in Pharmacology. 2023 Jan 1;14.
6- Mahdinia E, Shokri N, Taheri AT, Asgharzadeh S, Elahimanesh M, Najafi M. Cellular crosstalk in atherosclerotic plaque microenvironment. Cell Communication and Signaling. 2023 May 30;21(1):125.
7- Elahimanesh M, Najafi M. Cross talk between bacterial and human gene networks enriched using ncRNAs in IBD disease. Scientific Reports. 2023 May 11;13(1):7704.
8- Zahedi Bialvaei A, Eslami P, Ganji L, Dolatyar Dehkharghani A, Asgari F, Koupahi H, Barzegarian Pashacolaei HR, Rahbar M. Prevalence and epidemiological investigation of mgrB-dependent colistin resistance in extensively drug resistant Klebsiella pneumoniae in Iran. Scientific Reports. 2023 Jul 1;13(1):10680.
9- Motamedi H, Alvandi A, Fathollahi M, Ari MM, Moradi S, Moradi J, Abiri R. In silico designing and immunoinformatics analysis of a novel peptide vaccine against metallo-beta-lactamase (VIM and IMP) variants. PloS One. 2023 Jul 20;18(7):e0275237.
10- Narimisa N, Razavi S, Khoshbayan A, Masjedian Jazi F. Prevalence of Brucella endocarditis: A systematic review and meta‐analysis. Health Science Reports. 2023 May;6(5):e1301.
11- Davarpanah M, Bialvaei AZ. Prevalence, antimicrobial resistance, and biofilm-formation of Listeria monocytogenes in bulk raw milk in East Azerbaijan province, Iran. Reviews and Research in Medical Microbiology. 2023 Apr 1;34(2):73-8.
12- Navidifar T, Mahdizadeari M, Alipourkermani A, Afifirad R, Asadollahi P, Veisi A, Ghanavati R, Darbandi A. Clinical Efficacy of Probiotics for Oral Health: A Systematic Review of Clinical Trials. Current Pharmaceutical Biotechnology. 2023.
13- Darbandi A, Ohadi E, Nezamzadeh F, Jalalifar S, Zahedi Bialvaei A. The Effect of Climate Changes on human Bacterial infectious diseases. Iranian Journal of Medical Microbiology. 2023 Jun 10;17(3):273-87.
14- Soleimani AA, Shokri N, Elahimanesh M, Mohammadi P, Parvaz N, Bakhshandeh M, Najafi M. Beta arrestin‐related signalling axes are influenced by dexamethasone and metformin in vascular smooth muscle cells cultured in high glucose condition. Endocrinology, Diabetes & Metabolism. 2023 Dec 15:e465.
15- Ohadi E, Azarnezhad A, Lotfollahi L, Asadollahi P, Kaviar VH, Razavi S, Sadeghi Kalani B. Evaluation of Genetic Content of the CRISPR Locus in Listeria monocytogenes Isolated From Clinical, Food, Seafood and Animal Samples in Iran. Current Microbiology. 2023 Dec;80(12):388.
16- Teymouri S, Chegini Z, Naseripour M, Aghaei H, Darbandi A, Bostanghadiri N, Razavi S. Molecular Analysis of the Ocular Microbiome Dominant Bacteria in Conjunctival Squamous Cell Carcinoma Patients. Iranian Journal of Medical Microbiology. 2023 Dec 10;17(6):654-62
17- Jalalifar S, Razavi S, Mirzaei R, Irajian G, Pooshang Bagheri K. A hope for ineffective antibiotics to return to treatment: investigating the anti-biofilm potential of melittin alone and in combination with penicillin and oxacillin against multidrug resistant-MRSA and-VRSA. Frontiers in Microbiology. 2024 Feb 1;14:1269392.
18- Bostanghadiri N, Razavi S, Shariati A, Talebi M, Mirkalantari S, Emami Razavi A, Darban-Sarokhalil D. Exploring the interplay between Fusobacterium nucleatum with the expression of microRNA, and inflammatory mediators in colorectal cancer. Frontiers in Microbiology. 2023 Nov 23;14:1302719.
19- Amini SM, Getso MI, Farahyar S, Khodavaisy S, Roudbary M, Mahabadi VP, Mahmoudi S. Antifungal activity of green-synthesized curcumin-coated silver nanoparticles alone and in combination with fluconazole and itraconazole against Candida and Aspergillus species. Current Medical Mycology. 2023 Sep;9(3):38.